4/24
04:00 pm
mura
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Low
Report
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4/9
04:00 pm
mura
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
Low
Report
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
4/4
04:00 pm
mura
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/4
08:04 am
mura
Mural Oncology plc (NASDAQ: MURA) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $13.00 price target on the stock.
Medium
Report
Mural Oncology plc (NASDAQ: MURA) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $13.00 price target on the stock.
3/26
08:25 am
mura
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development [Yahoo! Finance]
Neutral
Report
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development [Yahoo! Finance]
3/26
07:00 am
mura
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Medium
Report
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
3/5
04:35 pm
mura
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Low
Report
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
3/4
04:15 pm
mura
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/27
07:00 am
mura
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
Medium
Report
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
2/5
04:30 pm
mura
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)